Document is current
Any future updates will be listed below
-
Authors
Rinaldi, G.
Cheng, K. K. W.
McCann, C.
Rossi, F.
Rodriguez-Rios, M.
Dhaliwal, K.
Bebes, A.
Duncan, L.
Yuecel, R.
Rossi, Adriano G.
Robb, Calum T.
-
Funding
Funding for this research was provided by:
OPTIMA (EP/L016559/1)
Wellcome Trust (320097/Z/24/Z)
Medical Research Council (MRC/K013386/1)
Antimicrobial Resistance UK (AMR) cross-council funding from the MRC to the SHIELD consortium (MRNO2995X/1)
- License Information
-
More Information
Article History
Received: 5 January 2026
Accepted: 5 February 2026
First Online: 18 February 2026
Declarations
:
: The authors declare no competing interests.
: AGR received a minor consultancy fee from Adiso Therapeutics for work that is unrelated to the present study. AGR also serves as the co-Editor-in-Chief of the Journal of Inflammation. To ensure impartiality, the peer-review of this manuscript was handled by an independent member of the editorial board, and the submission underwent the standard review process applied to all manuscripts.
